Jan 30, 10:40 Transfer news and rumours: Victor Boniface to Al-Nassr, Luis Guilherme to Shakhtar Donetsk, Eli Junior Kroupi to Bournemouth Sports Mole rounds up the latest transfer news and ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. By Rebecca Robbins and Gina Kolata Encouraging ...

Giants fans surely don’t look back on cornerback Eli Apple’s tenure with New York very fondly. The 10th overall pick in the 2016 NFL Draft, solidly known as a draft bust amongst Giants fans ...

Ore Huiying / Bloomberg / Getty Images Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released Phase 3 trial results for its oral weight-loss drug that ...

Exclusive: Creators Roth and Noah Belson celebrated the hidden gem's 25th anniversary with IndieWire. We’ve seen horror director Eli Roth split open skulls before, but the jack-of-many-trades ...

Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...

Drugmaker Eli Lilly announced promising Phase 3 study results for its new GLP-1 pill. Orforglipron is a drug similar to Ozempic but without the injection, making it more accessible. The pill ...

Eli Lilly announced a successful Phase 3 clinical trial of its new GLP-1 weight loss drug, orforglipron, which comes in pill form -- not an injection. This first trial showed weight loss of 7.9% ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best long term stocks. Dividend-paying stocks have traditionally been seen as a solid ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other other firms that ended the week strong. The stock market ended the shortened trading ...

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, establishing leadership in obesity treatment. Orforglipron offers advantages ...